# Verb Biotics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/verb-biotics

- Industry: Biotechnology
- Headquarters: Boston, US
- Website: www.verbbiotics.com
- Total disclosed funding: $30M
- Latest round: Series A (Sep 9, 2021)
- Investors on record: 2

## About

Based in Massachusetts, US, and founded in 2021, Verb Biotics, LLC, designs new probiotic bacteria with advanced properties for human nutrition, health, and wellness. In September 2021, Verb Biotics, LLC, raised USD 30 million in series A funding from investors Cascade Investment and Viking Global Investors. As of October 2021, the company’s CEO is Todd Beckman.

Verb Biotics, LLC, focuses on developing precise biotic-tech solutions for the food, beverage, and supplements industries. Verb Biotics delivers a variety of Probiotics, Postbiotics, and Synbiotics that give focused, measurable impacts to improve customer wellness. The company's product lineup includes probiotics, live organisms with health benefits; postbiotics, health-promoting components derived from inanimate organisms, and synbiotics, harmonious blends of pre/probiotics beneficial for host health.

## Funding rounds

- Series A, Sep 9, 2021, $30M — Cascade Investment, Viking Global Investors

## Investors

- Cascade Investment — Series A
- Viking Global Investors (https://capitalatlas.ai/funds/viking-global-investors) — Series A